Inpharma Weekly

, Volume 1220, Issue 1, pp 22–22 | Cite as

Zanamivir [`Relenza'; Glaxo Wellcome] has been approved in Japan

Media release
  • 3 Downloads

Keywords

Influenza Member State Medium Release Zanamivir Neuraminidase Inhibitor 

Copyright information

© Adis International Ltd 2000

Personalised recommendations